What determines end-of-life outcomes for consumer products? Insights from the Japanese experience

2008 ◽  
Vol 5 (4) ◽  
pp. 361 ◽  
Author(s):  
Y. Ogushi ◽  
M. Kandlikar ◽  
H. Dowlatabadi
2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 6117-6117
Author(s):  
E. T. Loggers ◽  
E. Soto ◽  
S. Desanto-Madeya ◽  
A. A. Wright ◽  
H. Stieglitz ◽  
...  

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 9525-9525
Author(s):  
Kathryn Elizabeth Hudson ◽  
Steven Paul Wolf ◽  
Amy Pickar Abernethy ◽  
Thomas William LeBlanc

2018 ◽  
Vol 21 (4) ◽  
pp. 536-540 ◽  
Author(s):  
Keiko Kurita ◽  
M. Cary Reid ◽  
Eugenia L. Siegler ◽  
Eli L. Diamond ◽  
Holly G. Prigerson

2021 ◽  
Author(s):  
Ping-Jen Chen ◽  
Lisanne Smits ◽  
Rose Miranda ◽  
Jung-Yu Liao ◽  
Irene Petersen ◽  
...  

Abstract Background: Home healthcare (HHC) may reduce acute hospital utilization, but its effect on homebound people living with dementia (PLWD) at end-of-life remains unclear. We aim to describe the impact of HHC on acute healthcare utilization and end-of-life outcomes in PLWD.Methods: Design: A systematic review of quantitative and qualitative studies regarding the association between HHC (exposure) and targeted outcomes. Interventions: HHC provided by health care professionals, including physicians or nurses. Participants: At least 80% of study participants had dementia and lived at home. Measurements: Primary outcome was acute healthcare utilization in the last year of life. Secondary outcomes included palliative care use, advance care planning (ACP), continuity of care in the last year of life, and place of death. We identified contextual information about policy changes in HHC for these outcomes.Results: We included five studies from USA, Japan, and Italy, none of which received a high-quality rating. At micro-level, HHC may be associated with a lower risk of acute healthcare utilization in the early period (e.g., last 90 days before death) and a higher risk in the late period (e.g. last 15 days) of the disease trajectory toward end-of-life in PLWD. ACP with written decisions may be an important mediator of this. HHC increases referrals to palliative care. At meso-level, HHC providers’ difficulty in making treatment decisions for PLWD at the end-of-life may require further training and external support. Coordination between HHC and social care is mentioned but not well examined in the existing literature.Conclusions: The review highlights the dearth of dementia-specific research regarding the impact of HHC on end-of-life outcomes. In PLWD, the core components of HHC for achieving better quality end-of-life, the integration between health and social care, and coordination between primary HHC and palliative care should be further investigated in future studies.


2016 ◽  
Vol 12 (10) ◽  
pp. e933-e943 ◽  
Author(s):  
Jeffrey D. Clough ◽  
Larisa M. Strawbridge ◽  
Thomas W. LeBlanc ◽  
Bradley G. Hammill ◽  
Arif H. Kamal

Purpose: To determine the relationships between hospital use of treating oncology practices and patient outcomes. Patients and Methods: Retrospective analysis of 397,646 Medicare beneficiaries who received anticancer therapy in 2012. Each beneficiary was associated with a practice; practices were ranked on the basis of risk-adjusted hospital use, that is, inpatient intensity. Outcomes included 30-day readmission, weekend admissions, intensive care unit stays in the last month of life, and hospice stay of ≥ 7 days. Outcomes were measured for each quartile of practice-level inpatient intensity. We fit multivariable logistic regression models to calculate adjusted odds ratios (ORs) for each outcome for each quartile of inpatient intensity. Results: Total 30-day readmissions were 22.8% and 31.9% (OR, 1.45; 95% CI, 1.39 to 1.50) for patients in practices with the lowest versus highest quartiles of inpatient intensity, respectively; unplanned readmissions were 19.8% and 27.1% (OR, 1.36; 95% CI, 1.31 to 1.41), respectively. The proportion of admissions that occurred on weekends was similar across quartiles. Patients of practices in the highest quartiles of inpatient intensity had higher rates of death in an ICU stay in the last month of life (25.5% versus 18.0%; OR, 1.33; 95% CI, 1.19 to 1.49) and a lower rate of hospice stay of at least 7 days (50.9% to 42.5%; OR, 0.79; 95% CI, 0.74 to 0.86). Conclusion: Medical oncology practices that seek to reduce hospitalizations should consider focusing initially on processes related to end-of-life care and care transitions.


Author(s):  
Ari Pelcovits ◽  
Adam J. Olszewski ◽  
Dominic Decker ◽  
Dana Guyer ◽  
Thomas W. Leblanc ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document